Praz 0.25mg (alprazolam): Uses, Dosage & Side Effects

What it's for (Indications)

Alprazolam, a short-acting benzodiazepine, is primarily indicated for the acute symptomatic treatment of specific anxiety and panic disorders in adults.
Its established clinical efficacy supports its use in the management of moderate to severe Generalized Anxiety Disorder (GAD).
In this context, alprazolam is prescribed to alleviate a constellation of distressing symptoms including persistent and excessive worry, tension, restlessness, irritability, muscle aches, and sleep disturbances, thereby aiming to improve the patient's daily functioning and reduce their subjective experience of anxiety.
Beyond GAD, alprazolam is also a cornerstone medication for the treatment of Panic Disorder, with or without agoraphobia.
For individuals suffering from panic disorder, alprazolam is utilized to reduce the frequency and intensity of unexpected panic attacks, which are characterized by sudden, overwhelming surges of fear or discomfort accompanied by prominent physical and cognitive symptoms such as palpitations, shortness of breath, dizziness, chest pain, fear of losing control, or fear of dying.
Due to its rapid onset of action, alprazolam can provide prompt relief from acute anxiety and panic symptoms.
However, consistent with current medical guidelines for benzodiazepines, its use is generally recommended for short-term management or as an intermittent adjunctive therapy due to concerns regarding dependence and withdrawal, and its prescription should always be part of a comprehensive treatment plan supervised by a healthcare professional.

Dosage Information

Type	Guideline
Standard	Dosage must be individualized and adjusted based on patient response and tolerability. For immediate-release formulations (e.g., as prescribed in Pakistan): Typical starting oral dose for adults (18-64 years) is 0.25mg to 0.5mg, taken three times daily. The doctor may increase the dose as required in different conditions. For extended-release formulations (e.g., as per US FDA guidelines): The recommended starting oral dosage is 0.5mg to 1mg once daily, preferably in the morning. Depending on the response, the dosage may be increased at intervals of 3 to 4 days, in increments of no more than 1mg daily. The recommended total daily dosage is typically 3mg to 6mg daily. Extended-release tablets should be swallowed whole and not divided, crushed, or chewed. General Administration Advice: Alprazolam should always be used as prescribed by a doctor and not in more than required doses. The full course of therapy should be completed even if symptoms subside. Tablets should be stored at room temperature, away from sources of moisture and light. When discontinuing or reducing the dose, a gradual tapering schedule is essential; typically, the dosage should be decreased by no more than 0.5mg every 3 days, though some patients may require an even slower reduction. Special consideration for dosage adjustments in geriatric patients, patients with hepatic impairment, and when used with ritonavir should be made in consultation with full prescribing information.

Type

Guideline

Standard

Dosage must be individualized and adjusted based on patient response and tolerability. **For immediate-release formulations (e.g., as prescribed in Pakistan):** Typical starting oral dose for adults (18-64 years) is 0.25mg to 0.5mg, taken three times daily. The doctor may increase the dose as required in different conditions. **For extended-release formulations (e.g., as per US FDA guidelines):** The recommended starting oral dosage is 0.5mg to 1mg once daily, preferably in the morning. Depending on the response, the dosage may be increased at intervals of 3 to 4 days, in increments of no more than 1mg daily. The recommended total daily dosage is typically 3mg to 6mg daily. Extended-release tablets should be swallowed whole and not divided, crushed, or chewed. **General Administration Advice:** Alprazolam should always be used as prescribed by a doctor and not in more than required doses. The full course of therapy should be completed even if symptoms subside. Tablets should be stored at room temperature, away from sources of moisture and light. When discontinuing or reducing the dose, a gradual tapering schedule is essential; typically, the dosage should be decreased by no more than 0.5mg every 3 days, though some patients may require an even slower reduction. Special consideration for dosage adjustments in geriatric patients, patients with hepatic impairment, and when used with ritonavir should be made in consultation with full prescribing information.

Safety & Warnings

Common Side Effects

Common side effects include depression, drowsiness (somnolence), headache, constipation, dry mouth, diarrhea, insomnia, restlessness, dizziness (lightheadedness), tremor, blurred vision, gastrointestinal upset (e.
g.
, nausea), weakness, memory impairment, dysarthria, abnormal coordination, ataxia, and decreased libido.
In elderly demented patients, there is an increased risk of stroke and transient ischemic attack (mini-stroke).

Serious Warnings

Black Box Warning: WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS. Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation.
Patients should be advised about the significant risks associated with alprazolam use.
**Dependence, Abuse, and Withdrawal:** Alprazolam has a high potential for abuse, misuse, and addiction, especially in individuals with a history of substance use disorders.
Abrupt discontinuation or rapid dose reduction can lead to severe withdrawal symptoms, which may be life-threatening.
Dosage should be tapered gradually under medical supervision.
**CNS Depression:** Alprazolam can cause profound sedation, somnolence, and impaired coordination.
Patients should avoid driving or operating heavy machinery until they know how the medication affects them.
Alcohol consumption should be strictly avoided due to increased CNS depressant effects.
Grapefruit and grapefruit-containing foods should also be avoided as they can increase alprazolam's side effects.
**Pre-existing Conditions:** Use with caution in patients with hepatic (liver) impairment, dementia (particularly in the elderly), tardive dyskinesia, a history of seizures, diabetes, narrow-angle glaucoma, alcohol abuse disorder, obesity, severe lung disease, or signs of neuroleptic syndrome.
**Depression and Suicidal Ideation:** Alprazolam may worsen pre-existing depression or lead to suicidal thoughts; patients should report any such changes to their doctor immediately.
**Allergic Reactions:** Severe allergic reactions, including angioedema, have been reported.
The medication is contraindicated in patients with known hypersensitivity to alprazolam or other benzodiazepines.
**Long-Term Use:** If used for a very long time, the medication may become less effective; patients should inform their doctor if this occurs.
**Neonatal Sedation and Withdrawal Syndrome:** Use during pregnancy can lead to neonatal sedation and withdrawal syndrome.

How it Works (Mechanism of Action)

Alprazolam is a 1,4 benzodiazepine. It exerts its effects by binding to the benzodiazepine site of gamma-aminobutyric acid-A (GABA-A) receptors in the brain, thereby enhancing GABA-mediated synaptic inhibition.